scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1161/01.HYP.35.5.1021 |
P698 | PubMed publication ID | 10818056 |
P2093 | author name string | D Levy | |
H R Black | |||
J L Izzo | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systole | Q496359 |
P304 | page(s) | 1021-1024 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | Clinical Advisory Statement. Importance of systolic blood pressure in older Americans | |
P478 | volume | 35 |
Q63811737 | 70-year legacy of the Framingham Heart Study |
Q53646825 | A 3-year follow-up study on the risk of stroke among patients with conjunctival haemorrhage. |
Q53281791 | A Systematic Review of Community Pharmacists' Interventions in Reducing Major Risk Factors for Cardiovascular Disease. |
Q73280063 | A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension |
Q36100478 | A prospective study of hypertension and risk of uterine leiomyomata. |
Q30493506 | Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder |
Q58043206 | Age-Dependent Association of the Polymorphisms in the Mitochondria-Shaping Gene, OPA1, With Blood Pressure and Hypertension in Korean Population |
Q79209136 | Aggressive blood pressure control in general practice (ABC-GP) study: can the new targets be reached? |
Q47302802 | Agreement between finger plethysmography- and brachial oscillometry-derived blood pressure measurements |
Q33802590 | Alterations of pulse pressure stimulate arterial wall matrix remodeling |
Q34659813 | An almond-enriched diet increases plasma α-tocopherol and improves vascular function but does not affect oxidative stress markers or lipid levels. |
Q36503368 | Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria |
Q37803362 | Are there benefits of antihypertensive therapy beyond blood pressure lowering? |
Q36745562 | Artery buckling: new phenotypes, models, and applications |
Q36632123 | Assessing the effects of non-steroidal anti-inflammatory drugs on antihypertensive drug therapy using post-marketing surveillance database |
Q33933733 | Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. |
Q35795083 | Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study |
Q46421135 | Biodemography: new approaches to understanding trends and differences in population health and mortality. |
Q37323794 | Biomarkers related to aging in human populations. |
Q35876466 | Blood pressure and progression of chronic kidney disease: importance of systolic, diastolic, or diurnal variation |
Q34509411 | Blood pressure as a surrogate end point for hypertension |
Q37152530 | Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease |
Q37593677 | Blood pressure control in the elderly: can you have too much of a good thing? |
Q35060141 | Blood pressure trajectories prior to death in patients with diabetes. |
Q36536160 | Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension |
Q40715158 | Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. |
Q37418437 | Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. |
Q44512007 | Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats. |
Q91559989 | Central blood pressure and pulse wave velocity in young and middle-aged Japanese adults with isolated systolic hypertension |
Q35013807 | Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists |
Q48442332 | Clinical predictors of the response to short-term thiazide treatment in nondiabetic essential hypertensives |
Q37779805 | Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide |
Q35066109 | Comparative prognostic value of systolic, diastolic, and pulse pressure. |
Q36038531 | Control of hypertension in eastern saudi arabia: results of screening campaign |
Q49043410 | Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension |
Q91642874 | Effective coverage for hypertension treatment among middle-aged adults and the older population in China, 2011 to 2013: A nationwide longitudinal study |
Q34574399 | Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema |
Q46965412 | Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study |
Q46823672 | Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy |
Q64128637 | Elevated blood pressure among U.S. adults with diabetes, 1988-1994 |
Q48727534 | Expanding the definition and classification of hypertension |
Q35590906 | Fetal origin of vascular aging |
Q30543372 | Fixed combination lisinopril plus hydro-chlorothiazide in the treatment of essential arterial hypertension: an opened, multi-centre, prospective clinical trial |
Q38544207 | Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation? |
Q47915689 | Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing |
Q35965890 | Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey. |
Q52000855 | Health care cost of analgesic use in hypertensive patients. |
Q34199999 | How long should telomeres be? |
Q46612150 | How should COMET influence heart failure practice? |
Q35108210 | How well are we managing and monitoring high blood pressure? |
Q79613532 | Hypertension and peripheral arterial disease |
Q37050159 | Hypertension control in the elderly |
Q35185094 | Hypertension in the elderly: Are we all on the same wavelength? |
Q34584216 | Hypertension in the elderly: a review of the importance of systolic blood pressure elevation |
Q34722769 | Hypertension knowledge, awareness, and attitudes in a hypertensive population |
Q91807470 | Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China |
Q39705952 | Improved blood pressure control with a physician-nurse team and home blood pressure measurement |
Q36615562 | Improved lipids, diastolic pressure and kidney function are potential contributors to familial longevity: a study on 60 Chinese centenarian families |
Q95300991 | Indian guidelines on hypertension-IV (2019) |
Q38844317 | Is Chinese herbal medicine effective for elderly isolated systolic hypertension? A systematic review and meta-analysis. |
Q44401500 | Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adult population? Tehran lipid and glucose study (TLGS). |
Q38735436 | Isolated Systolic Hypertension in Young Individuals: Pathophysiological Mechanisms, Prognostic Significance, and Clinical Implications |
Q77491750 | Isolated Systolic Hypertension in the Elderly |
Q64985803 | Isolated systolic hypertension of the young and its association with central blood pressure in a large multi-ethnic population. The HELIUS study. |
Q36718515 | Knowledge, Awareness and Self-Care Practices of Hypertension Among Cardiac Hypertensive Patients |
Q33568472 | Kā-HOLO Project: a protocol for a randomized controlled trial of a native cultural dance program for cardiovascular disease prevention in Native Hawaiians |
Q37145695 | Long-acting nifedipine in the management of the hypertensive patient |
Q46155651 | Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. |
Q37388460 | Management of hypertension in the elderly patient |
Q35886386 | Managing high-risk patients with hypertension: focus on the renin-angiotensin system |
Q27011805 | Managing hypertension in the elderly: a common chronic disease with increasing age |
Q35892516 | Mechanical buckling of artery under pulsatile pressure |
Q64255816 | Mediterranean-Style Diet Improves Systolic Blood Pressure and Arterial Stiffness in Older Adults |
Q36404975 | Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? |
Q37629587 | Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome |
Q37444168 | Nonpharmacological approaches in the management of hypertension |
Q37499002 | Now or never: optimal antihypertensive therapy in the elderly |
Q48531617 | Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. |
Q36013049 | Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension |
Q46148642 | Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization |
Q34584210 | Physician practice patterns in the treatment of isolated systolic hypertension in a primary care setting |
Q39377506 | Predictors of uncontrolled hypertension in the Stroke Belt. |
Q34179007 | Prehypertension: Underlying pathology and therapeutic options |
Q36905032 | Prehypertension: demographics, pathophysiology, and treatment |
Q44827601 | Prevalence and changes of untreated isolated systolic hypertension among non-Hispanic black adults in the United States |
Q36069784 | Prevalence and trends of isolated systolic hypertension among untreated adults in the United States |
Q33837558 | Prevalence of high blood pressure subtypes and its associations with BMI in Chinese children: a national cross-sectional survey. |
Q37126630 | Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older |
Q57605466 | Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study |
Q44727708 | Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. |
Q36893345 | Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension |
Q48070348 | Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria |
Q35904468 | Reactivity to a Spouse's Interpersonal Suffering in Late Life Marriage: A Mixed-Methods Approach |
Q35024225 | Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups |
Q33905072 | Relationship between psychosocial stress and hypertension among Ghanaians in Amsterdam, the Netherlands--the GHAIA study |
Q53317541 | Religious orientation, aging, and blood pressure reactivity to interpersonal and cognitive stressors. |
Q46866932 | Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension |
Q26766525 | Salt Reduction Interventions in Sub-Saharan Africa: A Systematic Review |
Q40692467 | Screening for eligibility in the study of antihypertensive medication in children: experience from the Ziac Pediatric Hypertension Study |
Q53712224 | Self-management approaches among hypertensive residents in nursing homes in Malaysia. |
Q92535598 | Serious adverse events in patients with target-oriented blood pressure management: a systematic review |
Q53424333 | Should beta blockers be used in the treatment of hypertension in the elderly? |
Q43407887 | Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. |
Q44809195 | Stagnation and the critical need for hypertension subtyping |
Q34661282 | Stress as a potential modifier of the impact of lead levels on blood pressure: the normative aging study |
Q44445417 | Systolic Hypertension in Hemodialysis Patients |
Q42780149 | Systolic blood pressure |
Q36812916 | Systolic blood pressure and adiposity: examination by race and gender in a nationally representative sample of young adults |
Q73137702 | Systolic blood pressure elevation: it's where the action is |
Q44003893 | Systolic vs diastolic blood pressure: community burden and impact on blood pressure staging |
Q34140863 | Telomeres: the time factor in essential hypertension |
Q73592652 | The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention |
Q44001365 | The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study |
Q36247350 | The association of educational attainment and SBP among older community-living adults: the Maintenance of Balance, Independent Living, Intellect and Zest in the Elderly (MOBILIZE) Boston Study |
Q35162676 | The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression |
Q30658320 | The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994. |
Q34209022 | The economic impact of hypertension |
Q36515508 | The older patient with hypertension: care and cure |
Q34158075 | The prevalence and heterogeneity of prehypertension: a meta-analysis and meta-regression of published literature worldwide |
Q39501461 | Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study |
Q37486470 | Transgenerational effect of fetal programming on vascular phenotype and reactivity in endothelial nitric oxide synthase knockout mouse model |
Q24239956 | Treatment blood pressure targets for hypertension |
Q35215068 | Treatment of hypertension in older patients: an updated look at the role of calcium antagonists |
Q36590817 | Treatment of isolated systolic hypertension |
Q35905180 | Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists |
Q50753534 | Trends in hypertension-related death in the United States: 1980-1998. |
Q35062333 | Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention |
Q64234857 | Undiagnosed Isolated Systolic and Diastolic Hypertension Subtypes and Their Correlates in Bangladesh: A Nationwide Survey |
Q34283117 | Update in pharmacologic treatment of hypertension |
Q36557652 | Vascular Health in American Football Players: Cardiovascular Risk Increased in Division III Players |
Q35108207 | What is the most important component of blood pressure: systolic, diastolic or pulse pressure? |
Q80871629 | [Arterial hypertension, chronic renal insufficiency and dialysis] |
Search more.